论文信息 - Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours. - 字舞流文

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

M. Piccart | J. Wanders | J. Verweij | P. Fumoleau | A. Awada | A. van der Gaast | D. Cutler | P. Statkevich | F. Eskens | H. Bleiberg | A. Gaast | M. Faber | D. Cutler | J. Wanders